Author

G. Aston-Jones

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Animal Behavior & Cognition· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Assay:behavioral assay· 2 Organism:rat· 2 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1

Frequent Co-Authors

C. B. Pantazis· 2 shared M. H. James· 2 shared A. Mohammadkhani· 1 shared A. Mohammdkhani· 1 shared H. E. Bowrey· 1 shared J. E. Fragale· 1 shared M. James· 1 shared

Activity by Year

2019-2019 · peak 3/yr

Co-Author Collaboration Network

7 top collaborators · 9 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersAnimal Behavior & Cognition

C. B. Pantazis

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The Role of Orexin-1 Receptor Signaling in Demand for the Opioid Fentanyl

J. E. Fragale, C. B. Pantazis, M. H. James, G. Aston-Jones

This study investigates how OxR1 antagonism affects fentanyl demand using behavioral economics and finds it increases demand elasticity but not consumption at zero cost.

bioRxiv · Jan 31, 2019Animal Behavior & Cognition

Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil

A. Mohammadkhani, M. James, G. Aston-Jones

This study examines the persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for remifentanil, showing prolonged behavioral changes beyond drug availability.

bioRxiv · Jan 17, 2019Animal Behavior & Cognition

Orexin-1 receptor signaling in ventral pallidum regulates demand for the opioid remifentanil

A. Mohammdkhani, C. B. Pantazis, H. E. Bowrey, M. H. James, G. Aston-Jones

This study shows that blocking orexin-1 receptor signaling in the ventral pallidum reduces motivation and relapse for the opioid remifentanil.

bioRxiv · Jan 9, 2019Animal Behavior & Cognition